Management of atrial fibrillation

被引:172
作者
Lip, Gregory Y. H. [1 ]
Tse, Hung-Fat
机构
[1] City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England
[2] Univ Hong Kong, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1016/S0140-6736(07)61300-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation is the most common sustained cardiac rhythm disorder, and confers a substantial mortality and morbidity from stroke, thromboembolism, heart failure, and impaired quality of life. With the increasingly elderly population in the developed world, as well as improvements in the management of myocardial infarction and heart failure, the prevalence of atrial fibrillation is increasing, resulting in a major public-health problem. This Review aims to provide an overview on the modern management of atrial fibrillation, with particular emphasis on pharmacological and non-pharmacological approaches. Irrespective of a rate-control or rhythm-control strategy, stroke prevention with appropriate thromboprophylaxis still remains central to the management of this common arrhythmia. Electrophysiological approaches could hold some promise for a curative approach in atrial fibrillation.
引用
收藏
页码:604 / 618
页数:15
相关论文
共 119 条
  • [1] Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
    Aguilar, M.
    Hart, R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [2] Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket'' approach
    Alboni, P
    Botto, GL
    Baldi, N
    Luzi, M
    Russo, V
    Gianfranchi, L
    Marchi, P
    Calzolari, M
    Solano, A
    Baroffio, R
    Gaggioli, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23) : 2384 - 2391
  • [3] Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
    Anand, Kishlay
    Mooss, Aryan N.
    Hee, Tom T.
    Mohiuddin, Syed M.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 217 - 222
  • [4] [Anonymous], 2004, Cochrane Database Syst Rev
  • [5] [Anonymous], 2003, CARD ARRHYTHMIAS H S
  • [6] *ANT TRIALL COLL, 1994, ARCH INTERN MED, V154, P1449
  • [7] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [8] Bayard Yves L, 2005, Expert Rev Cardiovasc Ther, V3, P1003, DOI 10.1586/14779072.3.6.1003
  • [9] Is atrial fibrillation an inflammatory disorder?
    Boos, CJ
    Anderson, RA
    Lip, GYH
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (02) : 136 - 149
  • [10] Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials
    Boos, CJ
    Lip, GYH
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (11) : 855 - 859